Predictors of Recurrence for High Risk Endometrial Cancer Patients

NCT04412902 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 92

Last updated 2020-12-09

No results posted yet for this study

Summary

This study will analyze whether there is any difference in recurrence and survival rates among the patients who received different adjuvant therapies.

Conditions

  • High-risk Endometrial Cancer

Interventions

DRUG

adjuvant therapy

Adjuvant chemotherapy and/or radiotherapy

Sponsors & Collaborators

  • Far Eastern Memorial Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-25
Primary Completion
2020-10-25
Completion
2020-11-25

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04412902 on ClinicalTrials.gov